Contemporary use of ceftaroline fosamil for the treatment of community-acquired bacterial pneumonia: CAPTURE study experience

Guidelines and Quality Measures

(2013) Jennie Johnstone et al.   INFECTIOUS DISEASE CLINICS OF NORTH AMERICA

In Vitro Activity of Ceftaroline Against Multidrug-Resistant Staphylococcus aureus and Streptococcus pneumoniae: A Review of Published Studies and the AWARE Surveillance Program (2008–2010)

(2012) David J. Farrell et al.   CLINICAL INFECTIOUS DISEASES

Summary of Ceftaroline Fosamil Clinical Trial Studies and Clinical Safety

(2012) Thomas M. File et al.   CLINICAL INFECTIOUS DISEASES

Prevalence of Methicillin-Resistant Staphylococcus aureus as an Etiology of Community-Acquired Pneumonia

(2012) G. J. Moran et al.   CLINICAL INFECTIOUS DISEASES

Activity of Ceftaroline and Epidemiologic Trends in Staphylococcus aureus Isolates Collected from 43 Medical Centers in the United States in 2009

(2011) Sandra S. Richter et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Guidelines for the management of adult lower respiratory tract infections - Summary

(2011) M. Woodhead et al.   CLINICAL MICROBIOLOGY AND INFECTION

Severity assessment tools in ICU patients with 2009 Influenza A (H1N1) pneumonia

(2011) J.M. Pereira et al.   CLINICAL MICROBIOLOGY AND INFECTION

Combination antibiotic therapy for community-acquired pneumonia

(2011) Jesus Caballero et al.   Annals of Intensive Care

Affinity of Ceftaroline and Other  -Lactams for Penicillin-Binding Proteins from Staphylococcus aureus and Streptococcus pneumoniae

(2010) K. Kosowska-Shick et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Integrated Analysis of FOCUS 1 and FOCUS 2: Randomized, Doubled‐Blinded, Multicenter Phase 3 Trials of the Efficacy and Safety of Ceftaroline Fosamil versus Ceftriaxone in Patients with Community‐Acquired Pneumonia

(2010) Thomas M. File et al.   CLINICAL INFECTIOUS DISEASES

Binding of ceftaroline to penicillin-binding proteins of Staphylococcus aureus and Streptococcus pneumoniae

(2010) H. Moisan et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

PIRO score for community-acquired pneumonia: A new prediction rule for assessment of severity in intensive care unit patients with community-acquired pneumonia*

(2009) Jordi Rello et al.   CRITICAL CARE MEDICINE

MRSA as a cause of community-acquired pneumonia

(2009) A. Nakou et al.   EUROPEAN RESPIRATORY JOURNAL

Ceftaroline: a cephalosporin with expanded Gram-positive activity

(2009) Zeina A Kanafani et al.   Future Microbiology

Dr. William H. Stewart: Mistaken or Maligned?

(2008) Brad Spellberg   CLINICAL INFECTIOUS DISEASES

Pneumonia Caused by Methicillin‐ResistantStaphylococcus aureus

(2008) Ethan Rubinstein et al.   CLINICAL INFECTIOUS DISEASES